Ocular surface physical polymer matrix

The ocular surface physical polymer matrix is a non-biological therapeutic entity used to manage ocular surface disorders, most notably dry eye disease. It is not a molecular target in the traditional sense (e.g., a receptor or enzyme) but rather a physical structure formed by the application of exogenous polymers like carboxymethylcellulose or hyaluronic acid (Jones et al., 2017). These polymers create a viscoelastic, mucomimetic layer that supplements the natural tear film, providing essential lubrication and hydration to the corneal and conjunctival epithelium. This matrix serves as a mechanical barrier against environmental irritants and reduces the friction associated with blinking, which is often elevated in patients with tear film instability (Messmer, 2015). By enhancing tear film break-up time and protecting the ocular surface from desiccation, these matrices help alleviate symptoms of irritation, redness, and foreign body sensation. While primarily palliative, the stabilization of the ocular environment can also support the healing of the corneal epithelium in chronic inflammatory conditions (AAO, 2023). Drugs interacting with this matrix are typically high-molecular-weight polymers that do not engage in biochemical signaling but instead provide mechanical relief. This approach remains a cornerstone of therapy for keratoconjunctivitis sicca, focusing on the physical restoration of the ocular environment.

Other names

Ocular lubricantTear film substituteMucomimetic polymer matrixArtificial tear filmArtificial tears

Physical lubrication and stabilization of the tear film through the formation of a viscoelastic polymer layer that mimics natural mucins and retains moisture on the ocular surface (Jones et al., 2017; Messmer, 2015).